Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.021 | 0.7 |